newsfilter
← Latest News
FDA Approved Drugs·

Approval of Cabometyx, Nda #208692 (Labeling)

Approval Date: 10/09/2025; Drug Name: Cabometyx, Nda #208692; Active Ingredients: CABOZANTINIB S-MALATE; Company: Exelixis Inc; Submission Status: Approval; Submission Classification: Labeling; Application Number: 208692

Company
EXELIXIS INC
Keywords
EXELIXIS INC